Kakamad Fahmi Hussein, Mustafa Mihr Naif, Yasin Shara Wahdaldeen, Xalid Shanga Sherzad, Mohammed Ayoob A, Othman Snur, Hiwa Dilan S, Abdullah Hiwa O, Abdalla Berun A, Nasralla Hawkar A, Ahmed Sasan M, Mustafa Ayman M, Hassan Shko H, Hussein Bushra O
College of Medicine, University of Sulaimani, Madam Mitterrand Street, Building 11, Apartment 50, Sulaymaniyah, Sulaymaniyah, Kurdistan, 46001, Iraq.
Scientific Affairs Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Kurdistan, Iraq.
J Cardiothorac Surg. 2024 Jul 31;19(1):473. doi: 10.1186/s13019-024-02951-0.
Carotid body tumors are uncommon neuroendocrine growths near the carotid bifurcation. While some advocate preoperative embolization to minimize bleeding, others avoid it due to complications. This study shares the experience of a single center in managing patients with carotid body tumors without practicing preoperative embolization.
This was a cross-sectional study of patients with carotid body tumors managed between 2020 and 2024. Data were collected from the hospital's registry. When necessary, routine blood tests, neck ultrasonography, and computed tomography scans were conducted. The tumors were categorized according to Shamblin's classification. The average duration of follow-up was 20 months.
The study involved 25 patients, 22 (88%) females and 3 (12%) males. Their ages ranged from 27 to 85 years old. Twenty (80%) cases presented with neck swelling, and six (24%) had a positive medical history. Tumors were mainly on the right side (52%), with 20 (80%) showing ill-defined neck masses. Tumor sizes ranged from 1.5 to 7 cm, with Shamblin type II tumors being discovered in the majority of cases (72%). Types of tumors were significantly associated with the tumor size (p-value < 0.05). Blood transfusion was required in five cases (20%), three from type III and two from type II, with none from type I (p-value = 0.001). Temporary neurological deficits occurred in 3 cases (12%). No functional impairment or mortality was recorded.
Carotid body tumors are rare tumors with an unknown etiology. Operation without practicing preoperative embolization may be feasible with an acceptable outcome.
颈动脉体瘤是颈动脉分叉处附近罕见的神经内分泌肿瘤。虽然一些人主张术前栓塞以尽量减少出血，但另一些人因并发症而避免使用。本研究分享了一个单中心在不进行术前栓塞的情况下管理颈动脉体瘤患者的经验。
这是一项对2020年至2024年间管理的颈动脉体瘤患者的横断面研究。数据从医院登记处收集。必要时，进行常规血液检查、颈部超声检查和计算机断层扫描。肿瘤根据沙姆林分类法进行分类。平均随访时间为20个月。
该研究涉及25名患者，22名（88%）为女性，3名（12%）为男性。他们的年龄在27岁至85岁之间。20例（80%）表现为颈部肿胀，6例（24%）有阳性病史。肿瘤主要位于右侧（52%），20例（80%）表现为颈部肿块边界不清。肿瘤大小从1.5厘米到7厘米不等，大多数病例（72%）为沙姆林II型肿瘤。肿瘤类型与肿瘤大小显著相关（p值<0.05）。5例（20%）需要输血，3例来自III型，2例来自II型，I型无输血病例（p值=0.001）。3例（12%）出现短暂性神经功能缺损。未记录到功能障碍或死亡。
颈动脉体瘤是病因不明的罕见肿瘤。不进行术前栓塞的手术可能是可行的，且结果可接受。
